Search results
iProtin® Reader
IVDR detector for precise quantitative measurement of Lp(a) and ApoB within 40 seconds. Important note: This device is intended exclusively for use with the iProtin® Lp(a) and iProtin® ApoB Test Kits.
iProtin® Lp(a) Test Kit
Measurement of Lp(a) for cardiovascular risk assessment, particularly in individuals with a family history or increased risk. Important note: This test is intended solely for use with the iProtin® Reader and is compatible only with this device.
iProtin® ApoB Test Kit
Measurement of ApoB for cardiovascular risk assessment. Important note: This test is intended solely for use with the iProtin® Reader and is compatible only with this device.
ZYMUTEST β2-Glycoprotein-1 Antigen
Assay proposed for the measurement of β2GP1 antigen in research applications.
ZYMUTEST vWF:CBA (Collagen Binding Assay)
Diagnosis of von Willebrand disease (vWD). Assay of vWF:CBA in clinical samples, as a disease marker or as an indicator for cardiovascular diseases.
ZYMUTEST vWF Antigen
Diagnosis of von Willebrand disease (vWD). Assay of vWF in clinical samples, as a disease marker or as an indicator for cardiovascular diseases. vWF deficiency associated with auto-antibodies to vWF (malignancy). High vWF concentrations in cardiovascular diseases.
ZYMUTEST tPA Antigen
Assay of tPA:Ag in clinical samples, as a disease marker. Assay of tPA:Ag in thrombolysis with recombinant tPA drugs. Assay of tPA:Ag as a cardiovascular disease marker.
ZYMUTEST Tissue Factor Total
Assay proposed for the measurement of total tissue factor in research application.
ZYMUTEST Tissue Factor
Assay proposed for the measurement of full length tissue factor in research application.
ZYMUTEST TAFI (Total) Antigen
High TAFI Ag concentrations involve a hypofibrinolytic status, which can induce an elevated risk of thrombosis. Measurement of TAFI Ag on plasma in order to diagnose a risk of a hypofibrinolysis resulting from an excess of TAFI.